Cynata Therapeutics Pink Sheet Forecast - 20 Period Moving Average

CYYNF Stock  USD 0.19  0.00  0.00%   
The 20 Period Moving Average forecasted value of Cynata Therapeutics Limited on the next trading day is expected to be 0.19 with a mean absolute deviation of 0 and the sum of the absolute errors of 0. Cynata Pink Sheet Forecast is based on your current time horizon. We recommend always using this module together with an analysis of Cynata Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
  
A commonly used 20-period moving average forecast model for Cynata Therapeutics Limited is based on a synthetically constructed Cynata Therapeuticsdaily price series in which the value for a trading day is replaced by the mean of that value and the values for 20 of preceding and succeeding time periods. This model is best suited for price series data that changes over time.

Cynata Therapeutics 20 Period Moving Average Price Forecast For the 13th of December 2024

Given 90 days horizon, the 20 Period Moving Average forecasted value of Cynata Therapeutics Limited on the next trading day is expected to be 0.19 with a mean absolute deviation of 0, mean absolute percentage error of 0, and the sum of the absolute errors of 0.
Please note that although there have been many attempts to predict Cynata Pink Sheet prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Cynata Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Cynata Therapeutics Pink Sheet Forecast Pattern

Backtest Cynata TherapeuticsCynata Therapeutics Price PredictionBuy or Sell Advice 

Cynata Therapeutics Forecasted Value

In the context of forecasting Cynata Therapeutics' Pink Sheet value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Cynata Therapeutics' downside and upside margins for the forecasting period are 0.19 and 0.19, respectively. We have considered Cynata Therapeutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
0.19
0.19
Expected Value
0.19
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the 20 Period Moving Average forecasting method's relative quality and the estimations of the prediction error of Cynata Therapeutics pink sheet data series using in forecasting. Note that when a statistical model is used to represent Cynata Therapeutics pink sheet, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria7.8794
BiasArithmetic mean of the errors None
MADMean absolute deviation0.0
MAPEMean absolute percentage error0.0
SAESum of the absolute errors0.0
The eieght-period moving average method has an advantage over other forecasting models in that it does smooth out peaks and valleys in a set of daily observations. Cynata Therapeutics 20-period moving average forecast can only be used reliably to predict one or two periods into the future.

Predictive Modules for Cynata Therapeutics

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Cynata Therapeutics. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.190.190.19
Details
Intrinsic
Valuation
LowRealHigh
0.160.160.21
Details

Other Forecasting Options for Cynata Therapeutics

For every potential investor in Cynata, whether a beginner or expert, Cynata Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Cynata Pink Sheet price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Cynata. Basic forecasting techniques help filter out the noise by identifying Cynata Therapeutics' price trends.

View Cynata Therapeutics Related Equities

 Risk & Return  Correlation

Cynata Therapeutics Technical and Predictive Analytics

The pink sheet market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Cynata Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Cynata Therapeutics' current price.

Cynata Therapeutics Market Strength Events

Market strength indicators help investors to evaluate how Cynata Therapeutics pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cynata Therapeutics shares will generate the highest return on investment. By undertsting and applying Cynata Therapeutics pink sheet market strength indicators, traders can identify Cynata Therapeutics Limited entry and exit signals to maximize returns.

Currently Active Assets on Macroaxis

Other Information on Investing in Cynata Pink Sheet

Cynata Therapeutics financial ratios help investors to determine whether Cynata Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cynata with respect to the benefits of owning Cynata Therapeutics security.